Background: Rates of medication discontinuation reflect factors including effectiveness,
tolerability, cost, and dosing frequency. Discontinuation data can be useful to physicians and …

Although great progress has been made in defining the spectrum of diseases known as
glaucoma, its pathogenesis is still poorly understood. One common element seems to be the …

Beta-blockers in modern glaucoma therapy. Review | Kiseleva | Ophthalmology in Russia
Ophthalmology in Russia Oftalʹmologiâ eng | рус User ISSN 1816-5095 (Print) ISSN 2500-0845 …

Topical β-blockers reduce the intraocular pressure (IOP) by blockade of sympathetic nerve
endings in the ciliary epithelium causing a fall in aqueous humour production. Two types of …

Background To compare the tolerability of commonly prescribed topical glaucoma
medications by determining frequency and bother of side effects, patient satisfaction with …

We undertook a non-concurrent prospective study of 191 Puerto Rican patients from August
1993 to April 1994. All patients had open angle glaucoma (OAG)(age ranged from 50 to 80 …

Background/aims: Topical β antagonists are prescribed for glaucoma in approximately 500
000 people in the United Kingdom. The authors have previously shown that topical β …

Most patients with relatively early glaucomatous damage can be satisfactorily managed with
topically or orally administered medications. These drugs, however, can sometimes cause …

Beta-blockers are among the most important groups of drugs for glaucoma therapy. The
advantages of beta-blockers are a good efficacy in primary and secondary types of …

BACKGROUND: Much experience has been gained with the use of older classes of
antiglaucoma agents—topical beta-adrenergic-receptor antagonists, nonselective …